Nonetheless, COVID-19-infected individuals have significantly higher levels of PAI-1 than those with diabetes or acute cerebral infarction, providing indirect evidence that COVID-19 could increase PAI-1 levels (Table 2). The gene discussed is SERPINE1; the disease is COVID-19.